30 Posts Not To Miss From ASCO 2026 Day 3
RASolute 302 Trial at ASCO 2026 Plennary Session: Daraxonrasib Improves Survival Versus Chemotherapy in Previously Treated Metastatic PDAC
Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology
LIBRETTO-432 Trial at ASCO 2026 Plenary Session: Adjuvant Selpercatinib in RET Fusion-Positive NSCLC
PROTEUS Trial at ASCO 2026 Plenary Session: Perioperative Apalutamide Plus ADT in High-Risk Localized or Locally Advanced Prostate Cancer.
Talha Badar: Key Hematologic Malignancy Posters from ASCO26
HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer
SARC041 Trail at ASCO 2026 Plenary Session: Abemaciclib in Advanced Dedifferentiated Liposarcoma
